Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209227 (US9266877, 173) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209199 (US9266877, 145) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209232 (US9266877, 178) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209211 (US9266877, 157) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209224 (US9266877, 170) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209205 (US9266877, 151) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209188 (US9266877, 134) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209151 (US9266877, 97) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209155 (US9266877, 101) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209201 (US9266877, 147) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209206 (US9266877, 152) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209226 (US9266877, 172) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209238 (US9266877, 184) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209097 (US9266877, 43) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209140 (US9266877, 86) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209216 (US9266877, 162) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209233 (US9266877, 179) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209236 (US9266877, 182) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209215 (US9266877, 161) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209209 (US9266877, 155) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209136 (US9266877, 82) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209127 (US9266877, 73) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209219 (US9266877, 165) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209185 (US9266877, 131) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209161 (US9266877, 107) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209223 (US9266877, 169) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209230 (US9266877, 176) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209095 (US9266877, 41) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209200 (US9266877, 146) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209103 (US9266877, 49) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209138 (US9266877, 84) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209139 (US9266877, 85) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209202 (US9266877, 148) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209074 (US9266877, 20) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209214 (US9266877, 160) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209222 (US9266877, 168) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209208 (US9266877, 154) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209210 (US9266877, 156) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209177 (US9266877, 123) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209183 (US9266877, 129) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209133 (US9266877, 79) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209197 (US9266877, 143) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209143 (US9266877, 89) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209231 (US9266877, 177) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209117 (US9266877, 63) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 27 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209145 (US9266877, 91) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209184 (US9266877, 130) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209220 (US9266877, 166) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209213 (US9266877, 159) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209229 (US9266877, 175) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 172 total ) | Next | Last >> |